Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis
Audience: Diabetes healthcare professionals, patients
[Posted 09/25/2009] FDA notified healthcare professionals and patients of revisions to the prescribing information for Januvia (sitagliptin) and Janumet (sitagliptin/metformin) to include information on reported cases of acute pancreatitis in patients using these products. Eighty-eight post-marketing cases of acute pancreatitis, including two cases of hemorrhagic or necrotizing pancreatitis in patients using sitagliptin, were reported to the Agency between October 2006 and February 2009. It is recommended that healthcare professionals monitor patients carefully for the development of pancreatitis after initiation or dose increases of sitagliptin or sitagliptin/metformin. Sitagliptin has not been studied in patients with a history of pancreatitis. Therefore, it is not known whether these patients are at an increased risk for developing pancreatitis and the medication should be used with caution and with appropriate monitoring in patients with a history of pancreatitis. Considerations for healthcare professionals, information for patients, and a Data Summary are provided.
_____________________________________________________________________________________
Today, there is no reason to use dangerous diabetic drugs! They are expensive and do Not cure the disease!
Alternative, natural approaches to treatment can control and even cure diabetes with none of the attendant problems associated with traditional diabetes drugs.
My name is Bill Young, I am the Editor of Natural Medical News. I am living proof. I was diagnosed with Type 2 diabetes in March of this year, 2009 and by August it was cured! You can cure your Type 2 diabetes by doing what I did: http://tw0.us/1Fp
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment